No Intervention (subjects were previously treated with Onglyza®)

OTHER3 trials

Sponsors

AstraZeneca, Assiut University, Sohag University

Conditions

Cesarean SectionDiabetes Mellitus, Type 2Maternal HealthRectal Carcinoma

Unknown Phase

Korean Post-marketing Surveillance for Onglyza®

CompletedNCT01575483

AstraZenecaDiabetes Mellitus, Type 2

Start: 2012-03-01End: 2016-09-07Updated: 2017-08-08

Robson Ten-Group Classification Study of Cesarean Section Rates in Assiut Hospitals

Not yet recruitingNCT07194876

Assiut UniversityCesarean Section, Maternal Health

Start: 2025-12-01End: 2027-02-01Target: 770Updated: 2025-09-26

Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma

Not yet recruitingNCT07363863

Sohag UniversityRectal Carcinoma

Start: 2026-03-01End: 2026-10-01Target: 100Updated: 2026-01-23